Ranbaxy Pharmaceuticals Canada Inc. (RPCI) is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India 's largest pharmaceutical company. RPCI is the first India-based pharmaceutical company to enter the Canadian market and the latest affiliate to join the Ranbaxy family of companies around the world. RPCI is engaged in the sale and distribution of affordable generic medicines in the Canadian healthcare system. Ranbaxy's R&D efficiencies and globally integrated systems enable RPCI to develop and manufacture pharmaceuticals to be brought to market quickly, efficiently, and at lower costs. As a result, we anticipate making a meaningful contribution to the healthcare system in Canada, as in other countries where we have done business.

Therapeutic Products Directorate (TPD) has already granted approval to RPCI to market a number of products in Canada.

Management Team

Canadian Management Team is led by a professional staff with extensive experience and knowledge in meeting the needs of the Canadian pharmaceutical market, they are:

Paul Drake General Manager	Anthony DiPierdomenico National Sales	James Erb Business Development
Pramod Pant Regulatory Affairs	Ajay Vashisht Finance and Commercial Operations